Over $16 billion of structured credit financings in Q1 2025
We advised on more than 40 structured credit transactions in the first quarter
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Vialto Partners completes recapitalization transaction
We advised an ad hoc group of first-lien lenders in connection with the transaction
Primo Brands $1.4 billion exchange offers and $3.85 billion financings
The transactions included new notes, the refinancing of a $3.1 billion term loan facility and a new $750 million revolving facility
Kantar $1.8 billion refinancing
The transaction comprised a high-yield notes offering and borrowing under an incremental term loan as part of a refinancing
Over $30 billion of structured credit financings in 2024
We advised on more than 85 structured credit transactions in 2024
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
Vialto Partners recapitalization
We are advising an ad hoc group of first-lien lenders in connection with the transaction
Boparan £470 million refinancing
We advised on a high-yield notes offering, tender offer and credit facility refinancing